FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileEdwards Lifesciences Corporation
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EW
Edwards Lifesciences Corporation Stock AnalysisComprehensive stock analysis for Edwards Lifesciences Corporation (EW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEW
EW
Edwards Lifesciences Corporation
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EW
  1. Home
  2. Stocks
  3. Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

🇺🇸EW•NYSE

Edwards Lifesciences Corporation

🇺🇸EW•NYSE
Market cap
$61.59B
Sentiment

Your view on EW

Mkt Cap
$61.59B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Edwards Lifesciences Corporation

Industry
Medical - Devices
Sector
Healthcare
CEO
Bernard J. Zovighian
Headquarters
One Edwards Way, Irvine, CA, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Bernard J. Zovighian
Headquarters
One Edwards Way, Irvine, CA, US
Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.

It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy.

In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation.

Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure.

The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Edwards Lifesciences Corporation from FRC's valuation model, read against the market price. EW last traded at $107.11, 60.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Edwards Lifesciences Corporation. Starting points for Edwards Lifesciences Corporation: P/E 60.2, EPS $1.77, beta 0.83 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Edwards Lifesciences Corporation. Edwards Lifesciences Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Edwards Lifesciences Corporation. Trailing twelve-month EPS for Edwards Lifesciences Corporation stands at $1.77. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$105.13

average of 15 firms, last 12 months

 

$105.13

Low $85.00

Median $110.00

High $120.00

 

Analyst Ratings

Buy18 firms, last 12 months
  • Strong Buy0
  • Buy15
  • Hold3
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$0.66$0.84$3.02$3.41
Low estimate$0.64$0.79$3.01$3.32
High estimate$0.74$0.86$3.06$3.49
No. of analysts16121717
Year-ago EPS$0.58$0.78$1.83—
Growth+14.3%+8.3%+64.9%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$1.71B$1.80B$6.81B$7.49B
Low estimate$1.70B$1.76B$6.73B$7.28B
High estimate$1.72B$1.83B$6.84B$7.54B
No. of analysts16122122
Year-ago revenue$1.57B$1.65B$6.07B—
Growth+8.9%+8.9%+12.3%—
Recent analyst actions15 rating and price-target changes, latest Nov 11, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Edwards Lifesciences Corporation. Edwards Lifesciences Corporation has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold EW19 companies · 8 funds
Compare EW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • AORTArtivion, Inc.Medical - Devices$901M
  • AVRAnteris Technologies Global Corp.Medical - Devices$556M
  • GNGBYGetinge AB (publ)Medical - Devices$6.1B
  • ISRGIntuitive Surgical, Inc.Medical - Instruments & Supplies$151.7B
  • LIVNLivaNova PLCMedical - Devices$5.1B
  • OCPNFOlympus CorporationMedical - Devices$10.6B
  • PENPenumbra, Inc.Medical - Devices$12.6B

More Medical - Devices companies

  • BIIOBionovate Technologies CorpOTC$775
  • BIOBio-Rad Laboratories, Inc.NYSE$9.7B
  • BIO-BBio-Rad Laboratories, Inc.NYSE$9.7B
  • BJDXBluejay Diagnostics, Inc.NASDAQ$3M
  • BMRABiomerica, Inc.NASDAQ$6M
  • BRKRBruker CorporationNASDAQ$9.3B
  • BRKRPBruker CorporationNASDAQ$9.3B
  • BRNHFBroncus Holding CorporationOTC$42M
  • BRSFBrain Scientific Inc.OTC$124
  • BSXBoston Scientific CorporationNYSE$63.3B
  • BTCYBiotricity, Inc.OTC$8M
  • BVSBioventus Inc.NASDAQ$716M

ETFs holding Edwards Lifesciences Corporation

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.08%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.07%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.51%
  • IVViShares Core SP 500 ETF$852.9B in assets0.10%
  • IHIiShares US Medical Devices ETF$4.0B in assets5.00%
  • BAFEBrown Advisory Flexible Equity ETF$1.7B in assets2.17%
  • BLCRiShares Large Cap Core Active ETF$9.8B in assets2.05%
  • JGLOJPMorgan Global Select Equity ETF$6.1B in assets1.01%

Largest holders first, then the funds most concentrated in EW.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Edwards Lifesciences Corporation, and how their positions are changing. At a $61.59B market value, institutional positions materially move Edwards Lifesciences Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Edwards Lifesciences Corporation executives and directors. Shares of Edwards Lifesciences Corporation have traded between $65.94 and $87.21 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Edwards Lifesciences Corporation. Edwards Lifesciences Corporation is a $61.59B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Edwards Lifesciences Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Edwards Lifesciences Corporation. Coverage tracks Edwards Lifesciences Corporation within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Edwards Lifesciences Corporation.

EW Analysis
Fair
Past3
Growth3
Health5
Profit2
Value1

News

Latest Market News